236 related articles for article (PubMed ID: 10429616)
1. Dynamic bone scintigraphy for evaluation of tumor response after preoperative chemotherapy. A retrospective study of osteosarcoma and Ewing's sarcoma patients.
Winderen M; Stenwig AE; Solheim OP; Saeter G; Aas M
Acta Orthop Scand Suppl; 1999 Jun; 285():11-7. PubMed ID: 10429616
[No Abstract] [Full Text] [Related]
2. Ultrasonographic monitoring of the effects of preoperative chemotherapy in osteosarcoma and Ewing's sarcoma.
Kinoshita T; Tatezaki S; Matsuzoki O; Inoue M
Int Orthop; 1995; 19(5):312-4. PubMed ID: 8567141
[TBL] [Abstract][Full Text] [Related]
3. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
4. Assessment of chemotherapy-induced changes in bone sarcomas: clinical experience with 99Tcm-MDP three-phase dynamic bone scintigraphy.
Ozcan Z; Burak Z; Kumanlioğlu K; Sabah D; Başdemir G; Bilkay B; Cetingül N; Ozkiliç H
Nucl Med Commun; 1999 Jan; 20(1):41-8. PubMed ID: 9949412
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.
Saleh MM; Abdelrahman TM; Madney Y; Mohamed G; Shokry AM; Moustafa AF
Br J Radiol; 2020 Nov; 93(1115):20200257. PubMed ID: 32706980
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery.
van der Woude HJ; Bloem JL; Verstraete KL; Taminiau AH; Nooy MA; Hogendoorn PC
AJR Am J Roentgenol; 1995 Sep; 165(3):593-8. PubMed ID: 7645476
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effect of preoperative chemotherapy in bone sarcomas. 99mTc-HMDP scintigraphy in 34 cases.
Kobayashi Y; Ozaki T; Takeda Y; Kawai A; Inoue H
Acta Orthop Scand; 1998 Dec; 69(6):611-6. PubMed ID: 9930108
[TBL] [Abstract][Full Text] [Related]
8. Case report: A rare case of Ewing's sarcoma and osteosarcoma at different sites 10 years apart.
Hosalkar HS; Atanda A; Barroeta J; Torbert JT; Lackman RD
Clin Orthop Relat Res; 2005 May; (434):273-7. PubMed ID: 15864064
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different.
Gaston LL; Di Bella C; Slavin J; Hicks RJ; Choong PF
Skeletal Radiol; 2011 Aug; 40(8):1007-15. PubMed ID: 21298431
[TBL] [Abstract][Full Text] [Related]
10. Thallium-201 scanning for the evaluation of osteosarcoma and soft-tissue sarcoma. A study of the evaluation and predictability of the histological response to chemotherapy.
Menendez LR; Fideler BM; Mirra J
J Bone Joint Surg Am; 1993 Apr; 75(4):526-31. PubMed ID: 8386728
[TBL] [Abstract][Full Text] [Related]
11. Flare response in Ewing's sarcoma.
Abdel Dayem HM; Caluser C
Clin Nucl Med; 1992 May; 17(5):419-20. PubMed ID: 1587053
[No Abstract] [Full Text] [Related]
12. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.
Franzius C; Sciuk J; Brinkschmidt C; Jürgens H; Schober O
Clin Nucl Med; 2000 Nov; 25(11):874-81. PubMed ID: 11079583
[TBL] [Abstract][Full Text] [Related]
13. Parametric imaging of 99mTc methylene diphosphonate biokinetics in osteosarcoma for preoperative evaluation of chemotherapy-induced necrosis.
Knop J; Delling G; Heise U; Winkler K
Chir Organi Mov; 1990; 75(1 Suppl):36-7. PubMed ID: 2249552
[No Abstract] [Full Text] [Related]
14. [Scintigraphy with 99mTc-MIBI for assessment of tumor response to preoperative chemotherapy in patients with osteosarcoma].
García-Fernández R; Hernández-Hernández DM; Iwasaki-Otake L; Mantilla-Morales A; Ortiz-Rodríguez L; Pichardo-Romero P; Lira-Puerto V
Rev Invest Clin; 2001; 53(4):324-9. PubMed ID: 11599479
[TBL] [Abstract][Full Text] [Related]
15. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy.
Shapeero LG; Henry-Amar M; Vanel D
Invest Radiol; 1992 Nov; 27(11):989-91. PubMed ID: 1464523
[No Abstract] [Full Text] [Related]
16. [The role of radiotherapy in the treatment of malignant bone tumors (author's transl)].
Scherer E; Weber R
Langenbecks Arch Chir; 1975 Nov; 339():327-34. PubMed ID: 1060907
[TBL] [Abstract][Full Text] [Related]
17. Can FDG-PET assess the response to chemotherapy and predict tissue necrosis in osteosarcoma and Ewing sarcoma?
Andreani L; Ipponi E; Ruinato AD; Lupi T; Di Sacco F; Volterrani D; Coccoli L; Capanna R
Folia Med (Plovdiv); 2024 Apr; 66(2):196-202. PubMed ID: 38690814
[TBL] [Abstract][Full Text] [Related]
18. Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.
Brisse H; Ollivier L; Edeline V; Pacquement H; Michon J; Glorion C; Neuenschwander S
Pediatr Radiol; 2004 Aug; 34(8):595-605. PubMed ID: 15103428
[TBL] [Abstract][Full Text] [Related]
19. [Place of the pathologist in the management of primary bone tumors (osteosarcoma and Ewing's family tumors after neoadjuvant treatment)].
Gomez-Brouchet A; Bouvier C; Decouvelaere AV; Larousserie F; Aubert S; Leroy X; Guinebretière JM; Coulomb A; Cassagnau E; de Muret A; Audard V; Marie B; de Pinieux G
Ann Pathol; 2011 Dec; 31(6):455-65. PubMed ID: 22172118
[TBL] [Abstract][Full Text] [Related]
20. Long-term scintigraphic appearance of extremities following bone tumor resection and allograft reconstruction.
Smith JT; Smith LM; Rinsky L; Goris ML
Clin Nucl Med; 1991 Dec; 16(12):907-9. PubMed ID: 1663013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
